Cancer Biology

805 Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs.

804 Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

803 Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma.

802 Using unique barcodes for tumour cells, the authors explore the dynamics of human glioblastoma subpopulations, and suggest that clonal heterogeneity emerges through stochastic fate decisions of a neutral proliferative hierarchy.

801 Large-scale enhancer reprogramming directed by transcription factors such as FOXA1 drives metastasis in the organoid model of pancreatic cancer.

800 Distinct tumor immune microenvironments co-exist within a single individual and may help to explain the heterogeneous fates of metastatic lesions often observed post-therapy.

799 Molecular machines open cell membranes.

798 Identification of essential genes for cancer immunotherapy.

797 CDK4/6 inhibition triggers anti-tumour immunity.

796 SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis.

795 Ultrastable Near-Infrared Conjugated-Polymer Nanoparticles for Dually Photoactive Tumor Inhibition.

794 Sequentially Responsive Shell-Stacked Nanoparticles for Deep Penetration into Solid Tumors.

793 Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers.

792 A pathology atlas of the human cancer transcriptome.

791 An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.

790 FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.

789 A pan-cancer biomarker is identified that can predict successful response to cancer immunotherapy in human patients.

788 In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.

787 Genome editing abrogates angiogenesis in vivo.

786 A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

Free Images for Presentation: sunipix SUNIPIX